MCGAULEY THOMAS (Interim CFO) purchased 8K shares of TENAX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $58.2K. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 11/19/2025ACC: 0001550701-25-000002
Officer· Interim CFO
Since Jan 2026
+8K
Net shares
Net buyer
$58.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
8K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2K
Price / share
$7.34
Trade value
$14.67K
% of position
New position
11/17/2025
0.00→2K
Common Stock
Indirect
Shares
+1K
Price / share
$7.35
Trade value
$7.35K
% of position
New position
11/17/2025
0.00→1K
Common Stock
Indirect
Shares
+5K
Price / share
$7.23
Trade value
$36.14K
% of position
New position
11/17/2025
0.00→5K
Total
Net shares
+8K
Net value
$58.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | P · Purchase | +2K | $7.34 | $14.67K | New position | 0.00 | 2K |
| Common Stock Indirect | 11/17/2025 | P · Purchase | +1K | $7.35 | $7.35K | New position | 0.00 | 1K |
| Common Stock Indirect | 11/17/2025 | P · Purchase | +5K | $7.23 | $36.14K | New position | 0.00 | 5K |
| Total | +8K | $58.16K | ||||||
Derivative Transactions0
No derivative transactions reported